Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ausrichter pty ltd - adenosine triphosphate; uridine triphosphate - parenteral liquid/solution/suspension - adenosine triphosphate nucleotide active 14.0 mg/ml; uridine triphosphate nucleotide active 2.0 mg/ml - nutrition & metabolism - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - muscular stimulant

United States - English - NLM (National Library of Medicine)

guna spa - adenosine triphosphate (unii: 8l70q75fxe) (adenosine triphosphate - unii:8l70q75fxe), .alpha.-ketoglutaric acid (unii: 8id597z82x) (.alpha.-ketoglutaric acid - unii:8id597z82x), .alpha.-lipoic acid (unii: 73y7p0k73y) (.alpha.-lipoic acid - unii:73y7p0k73y), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), barium oxalosuccinate (unii: l7a49804zq) (barium cation - unii:v645272hln), beet (unii: n487km8cok) (beet - unii:n487km8cok), cerous oxalate nonahydrate (unii: 0uv74p3r0j) (cerous - adenosine triphosphate 8 [hp_x] in 4 g - adenosintriphosphate    8x    cell metabolism alpha-ketoglutaric acid    6x    detoxification alpha-lipoic ac        6x    detoxification ascorbic acid        4x    cell metabolism barium oxalosuccinate    6x    detoxification beta vulgaris        2x    cell metabolism cerium oxalicum        6x    cell metabolism cis-aconitic acid    6x    cell metabolism coenzyme a        6x    cell metabolism cysteinum        6x    cell metabolism embryo extract        6x    cell metabolism fumaricum acidum    6x    anti-inflammatory ginseng            3x    detoxification glandula suprarenalis    10x    hormonal regulation lacticum acidum        8x    cell metabolism magnesium carbonate    2x    tiredness malic acid        6x    cell metabolism manganum phosphoricum    6x    tiredness

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - adenosine triphosphate (unii: 8l70q75fxe) (adenosine triphosphate - unii:8l70q75fxe) - adenosine triphosphate 8 [hp_x] in 1 ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jaydee laboratories pty ltd - potassium aspartate; magnesium aspartate; heptaminol hydrochloride; sodium selenite; adenosine triphosphate; uridine triphosphate; vitamin b12 = cyanocobalamin - parenteral liquid/solution/suspension - potassium aspartate amino acid-aspartate active 15.0 mg/ml; magnesium aspartate amino acid-aspartate active 15.0 mg/ml; heptaminol hydrochloride amine/amide active 5.0 mg/ml; sodium selenite mineral-selenium active 1.0 mg/ml; adenosine triphosphate nucleotide active 2.0 mg/ml; uridine triphosphate nucleotide active 1.0 mg/ml; vitamin b12 = cyanocobalamin vitamin-b12 active 0.5 mg/ml - nutrition & metabolism - dog | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at - muscular dystrophy | muscular stimulant | tying-up syndrome (horses)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - adenosine triphosphate - unknown - adenosine triphosphate nucleotide active 0.0 - active constituent

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection is indicated for the following. conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in: - second- or third-degree a-v block (except in patients with a functioning artificial pacemaker). - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning arti

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - adenosine triphosphate - musculoskeletal system - dog | dog - greyhound | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance h - intracellular energy production | muscle injury treatment | muscular contraction

United States - English - NLM (National Library of Medicine)

akorn - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection is indicated for the following. conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration ). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in: - second- or third-degree a-v block (except in patients with a functioning artificial pacemaker). - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning artificial pacemaker). - known hypersensitivity to adenosine.

United States - English - NLM (National Library of Medicine)

cardinal health - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection is indicated for the following. conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration ). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in:

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection is indicated for the following. conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration ). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in: - second- or third-degree a-v block (except in patients with a functioning artificial pacemaker). - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning art